Quintet Private Bank (Europe)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Sell
486,935
-10,713
-2% -$280K 0.73% 33
2026
Q1
$14M Sell
497,648
-8,656
-2% -$230K 0.94% 29
2025
Q4
$12.6M Sell
506,304
-14,877
-3% -$375K 0.73% 31
2025
Q3
$13.3M Buy
521,181
+52,658
+11% +$1.3M 0.74% 33
2025
Q2
$11.4M Buy
468,523
+108,608
+30% +$2.53M 0.66% 33
2025
Q1
$9.12M Buy
359,915
+23,332
+7% +$611K 0.54% 35
2024
Q4
$8.93M Sell
336,583
-21,420
-6% -$581K 0.49% 36
2024
Q3
$10.4M Buy
358,003
+46,016
+15% +$1.34M 0.59% 34
2024
Q2
$10.1M Sell
311,987
-33,671
-10% -$927K 0.59% 33
2024
Q1
$11.1M Sell
345,658
-107,410
-24% -$2.98M 0.49% 38
2023
Q4
$13M Sell
453,068
-6,184
-1% -$187K 0.81% 30
2023
Q3
$15.2M Buy
459,252
+68,462
+18% +$2.42M 1.02% 29
2023
Q2
$14.3M Buy
390,790
+67,531
+21% +$2.63M 0.69% 32
2023
Q1
$13.2M Buy
+323,259
New +$14M 0.78% 30
2022
Q2
$14.3M Buy
+390,790
New +$19.9M 0.69% 32

Other funds holding PFE

Quintet Private Bank (Europe)'s PFE Position: Q2 2026 in Review

Quintet Private Bank (Europe) reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $280K and leaving 486,935 shares worth $11.7M. The position accounts for 0.73% of the portfolio, ranked #33.

Quintet Private Bank (Europe) first reported a position in PFE in Q2 2022 and has held it in 15 quarters since. The position peaked at $15.2M in Q3 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quintet Private Bank (Europe) held 486,935 shares of Pfizer worth $11.7M as of Q2 2026.
  • Quintet Private Bank (Europe) sold 10,713 Pfizer shares in Q2 2026, an estimated $280K.
  • Pfizer made up 0.73% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #33 holding.
  • Quintet Private Bank (Europe) first reported a position in Pfizer in Q2 2022 and has held it in 15 quarters since.
  • Quintet Private Bank (Europe)'s Pfizer position peaked at $15.2M in Q3 2023.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.